![]() | |
Clinical data | |
---|---|
Trade names | Metheph, Methy-F, Tybraine |
Other names | N-Methylephedrine; N-Methyl-(–)-ephedrine; L-Methylephedrine; N-Methyl-L-ephedrine; (−)-N-Methylephedrine; N,N-Dimethylnorephedrine |
Drug class | Sympathomimetic; Norepinephrine releasing agent; Bronchodilator; Nasal decongestant; Antitussive |
Pharmacokinetic data | |
Metabolites | • Methylephedrine N-oxide [1] [2] • Ephedrine [1] [2] • Norephedrine [1] [2] |
Excretion | Urine [1] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.008.203 |
Chemical and physical data | |
Formula | C11H17NO |
Molar mass | 179.263 g·mol−1 |
3D model (JSmol) | |
| |
|
Methylephedrine, sold under the brand name Metheph among others, is a sympathomimetic medication described as an antiasthmatic agent and used to treat coughing and nasal congestion. [3] [4] [1] It is reported to be used in various over-the-counter cough and cold preparations throughout the world, including Japan. [1]
The drug is an ephedrine-like sympathomimetic and activates α- and β-adrenergic receptors. [5] Chemically, it is a substituted amphetamine and is closely related to ephedrine. [3] [4]
Methylephedrine was discovered by 1927. [6] It is mostly no longer marketed as a prescription drug. [4] The drug is also found naturally as an alkaloid in Ephedra species including Ephedra sinica , Ephedra vulgaris , and Ephedra distachya . [3] [6]
Rarely, heart failure and stroke in association with use of methylephedrine have been reported. [7] [8] [9]
Methylephedrine shows reinforcing effects, a measure of addiction and misuse potential, in monkeys. [10]
Methylephedrine is a sympathomimetic and ephedrine-like agent. [5] [1] Ephedrine and related agents act as norepinephrine releasing agents and hence as indirectly acting sympathomimetics. [1] In relation to this, methylephedrine stimulates α- and β-adrenergic receptors. [5] [1] The drug has bronchodilator and nasal decongestant effects. [5]
The occupancy of the dopamine transporter (DAT) by racemic methylephedrine has been studied. [11]
Methylephedrine is metabolized into ephedrine and norephedrine. [1] [2] It is excreted in urine 33 to 40% unchanged, 15% as methylephedrine N-oxide, and 8% as ephedrine after 24 hours. [1] [2]
Methylephedrine, also known as (1R,2S)-β-hydroxy-N,N-dimethyl-α-methyl-β-phenethylamine and as (1R,2S)-β-hydroxy-N,N-dimethylamphetamine, is a substituted phenethylamine and amphetamine derivative. [3] [4] It is the N-methylated derivative of ephedrine ((1R,2S)-β-hydroxy-N-methylamphetamine). [3] [4]
A closely related compound and stereoisomer of methylephedrine is N-methylpseudoephedrine. [3] Another related analogue is dimethylamphetamine (N,N-dimethylamphetamine), which is said to be a prodrug of methamphetamine and/or amphetamine. [12] Other analogues include etafedrine (N-ethylephedrine) and cinnamedrine (N-cinnamylephedrine). [3]
The experimental log P of methylephedrine is 2.47 and its predicted log P ranges from 1.7 to 1.74. [13] [1] [14]
In organic chemistry, N-methylephedrine is used as a resolving agent and as a precursor to chiral supporting electrolytes, phase-transfer catalysts, and reducing agents. [15]
Methylephedrine was discovered via isolation from Ephedra by 1927. [6]
Methylephedrine is the generic name of the drug and its BAN . [3] [4] [16] In the case of the hydrochloride salt, its generic name is methylephedrine hydrochloride and this is its BANM . [3] [4] [16] Brand names of methylephedrine include Metheph, Methy-F, and Tybraine, among others. [3] [4] [16]
Similarly to ephedrine, methylephedrine may have misuse potential. [1] [17] The drug shows reinforcing effects in monkeys. [10] It is one of the four constituents of BRON, a Japanese over-the-counter cough medicine with reports of misuse. [1] [17] However, addiction liability of BRON was attributed primarily to the codeine component. [17] A case report of addiction to methylephedrine exists. [9]
Methylephedrine is on the World Anti-Doping Agency's prohibited list. [5]